Total buying$00 buys
ONC
BeOne Medicines Ltd.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$22.6M16 sells
Net open-market−$22.6MBuying minus selling
Active insiders2Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 15, 2026
Open-market transaction mix · 16 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 11 | 0 | $0 | $11.7M | -$11.7M |
| Oct 2026 | 0 | 5 | 0 | $0 | $10.8M | -$10.8M |
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (2)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- WX-$19.9M
- LH-$418.1k
ONC transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$445kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$2.31MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$1.99MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$3.63MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$2.50MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | M · exercise10b5-1 detectedSEC filing ↗ | $1.14MView disclosure → | |
ONCBeOne Medicines Ltd. | Lee Chan HenrySVP · GC | S · sale10b5-1 detectedSEC filing ↗ | -$418kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$271kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$5.32MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$748kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$1.24MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$1.27MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$1.53MView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$809kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$14.3kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$43.0kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | S · sale10b5-1 detectedSEC filing ↗ | -$57.1kView disclosure → | |
ONCBeOne Medicines Ltd. | Wang XiaodongDIR | M · exercise10b5-1 detectedSEC filing ↗ | $1.14MView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period20transactionstxns
- S · Open-market sells · dominant16 · 80%
- M · Option exercise4 · 20%
Activity by reported role
A joint filing can contribute to multiple rolesDirector19
GC1
SVP1
Reported Holdings After
Separated by insider, security, and ownership type
Wang XiaodongAmerican Depositary Shares · Direct
0Oct 13, 2026
Wang XiaodongShare Option (Right to Buy) · Direct
403,364Oct 13, 2026
Lee Chan HenryAmerican Depositary Shares · Direct
0Sep 30, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
BeOne Medicines Ltd. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at BeOne Medicines Ltd.?
Wang Xiaodong, Lee Chan Henry.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Wang Xiaodong reported a sale on Oct 13, 2026 valued at $445k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $22,626,756.89. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.